NASDAQ · Key Statistics

Nanobiotix S.A. - ADSs (NBTX) Key Statistics

$29.36 NASDAQ: NBTX Market Cap $1.47B

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Nanobiotix S.A. - ADSs (NBTX), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-21.87
P/B ratioShare price divided by book value per share.	-35.23
P/S ratioMarket value divided by annual revenue.	142.86
PEG ratioP/E divided by the earnings growth rate.	0.18
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-37.35
EV / RevenueEnterprise value against annual revenue.	142.36
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-4.92%
Free cash flow yieldFree cash flow as a percentage of market value.	-3.20%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	100.00%
Operating marginRevenue left after operating costs.	-367.66%
Net marginRevenue left after every cost, including tax and interest.	-617.88%
Return on equityProfit as a percentage of shareholders’ equity.	89.71%
Return on assetsProfit as a percentage of total assets.	-41.20%
Return on capital employedOperating profit against the capital the business uses.	-74.19%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	1.44
Quick ratioThe same, excluding inventory.	1.44
Cash ratioCash alone against current liabilities.	0.91
Debt to equityTotal borrowings against shareholders’ equity.	-3.19
Debt to assetsTotal borrowings against total assets.	1.40
Interest coverageHow many times operating profit covers the interest bill.	-1.48

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-0.50
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$1.47B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$1.31B

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%

Nanobiotix S.A. - ADSs (NBTX) statistics — frequently asked questions

What is Nanobiotix S.A. - ADSs's P/E ratio?

Nanobiotix S.A. - ADSs (NBTX) trades on a price-to-earnings ratio of -21.87. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Nanobiotix S.A. - ADSs's return on equity?

Nanobiotix S.A. - ADSs (NBTX) reports a return on equity of 89.71%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Nanobiotix S.A. - ADSs carry?

Nanobiotix S.A. - ADSs (NBTX) has a debt-to-equity ratio of -3.19, which compares total borrowings with shareholders' equity.

What is Nanobiotix S.A. - ADSs's profit margin?

Nanobiotix S.A. - ADSs (NBTX) keeps -617.88% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.